Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-19

Clinical Trial Update: The Cardioprotective Effects of Adding Ozone To Cardioplegic Solution in Adult Cardiac Surgery [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update exploring the cardioprotective effects of adding ozone to cardioplegic solution in adult cardiac surgery, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozone (ozone)

Snippet

Sponsor: Assiut University | Conditions: Ischemic Heart Disease | Phase 2, Phase 3 | Status: UNKNOWN